top of page


Yevgeny Beiderman
CEO
Super Specta develops electro-optic device for Alzheimer’s disease (AD) early detection & deterioration follow-up, by real-time imaging of AD’s Bio-markers at the CerebroSpinal Fluid (CSF).
This is the only known non-invasive direct CSF analysis, and is Ionizing radiation free, pain free and risk free. Therefore, tests can be performed daily \ weekly, for frequent patient monitoring.
​
Along with AD, the system has the potential to monitor other degenerative brain diseases

PORTFOLIO
Product

DEVICES


PHARMA & BIOTECH


PHARMA & BIOTECH

bottom of page